AI Proteins

We are honored to be selected as a Falling Walls Foundation Venture winner! Our de novo designed #miniprotein therapeutics promise to be a game changer for patients, and this recognition is a testament to the hard work and dedication of our team. We can't wait to showcase our technology at the #FallingWalls #ScienceSummit24 in Berlin this November.

Special Dana-Farber Cancer Institute Targeted Protein Degradation Event Joins us in person or via zoom for an half-day of talks by Eric Fischer, Mikolaj Slabicki, Samantha Bevill, Pamela Ting, Liron Bar-Peled, and a panel featuring Samantha Nelson, Sheryl Gough, PhD and chris bahl. The panel will be followed by a reception, with a lot of time for networking! Event takes place on September 12th, 2024, from noon to 8PM EST at Linda K. Paresky Conference Center, Simmons University 300 Fenway Boston, MA 02115, and always over zoom for those of you who can't be with us in person. There is no fee to register thanks to the generous sponsorship from Amgen, Bruker, and Dana-Farber/Harvard Cancer Center. Thank you! FOR IN-PERSON EVENT REGISTER HERE: https://lnkd.in/evQPgHG6 FOR VIRTUAL EVENT REGISTER HERE: ttps://https://lnkd.in/eTbnhvh

I'm extremely grateful to the stellar team of collaborators that made it a joy to work on this story: Mireia Solà Colom, Jelena Vucinic, Jared Adolf-Bryfogle, James Bowman, Sébastien Verel, Isabelle M., Thomas Schiex, and David Simoncini and I'm very proud to have this work published in The Protein Society's journal Protein Science https://lnkd.in/ehaSGZcz

AI Proteins Expands Leadership Team With New Head Of Corporate Strategy Learn more & get our take 👇 https://lnkd.in/gAhzD2Ki “Mike brings tremendous knowledge across the spectrum of biotech, and we are confident he will help us to fully unlock the power of our high-throughput miniprotein platform. He’s a perfect fit for our crew as we are making our innovative tech a reality and designing promising therapies to help patients.” — Dr. chris bahl, Founder, President, and Chief Scientific Officer at AI Proteins “Mike’s expertise will help us to further prioritize and determine the best path for moving these programs forward into development, and ultimately to the patients who need them.” — Noah Beerman, Chief Executive Officer at AI Proteins “I am honored to be joining the company as we continue on our mission to create groundbreaking new drugs, and I welcome the opportunity to help AI Proteins achieve its amazing potential.” — Michael D Krepps, Head of Corporate Strategy at AI Proteins #lifesciences #leadership #SoHCNews

we're thrilled to welcome Michael D Krepps to our leadership team at AI Proteins as Head of Corporate Strategy! https://lnkd.in/eK__ah_j

With #BIO2024 coming up next week, we're excited to share a brief update on what we've been working on at AI Proteins https://lnkd.in/gxgSByVc

Join us in congratulating Vitaliy Andrusyshyn for two years of service at AIP!

Wendy Dwyer is looking to bring on a Director of Business Development to her team! This is an exciting time at AI Proteins and this role provides a great opportunity to be a part of groundbreaking work. Message me if you or someone you know would be a great fit.

We recently promoted four amazing employees. Please join us in congratulating Tessa H., Rohan Patel, James Bowman, and Frank Teets on the well-deserved recognition.

𝐀𝐥𝐢𝐠𝐧 𝐒𝐮𝐦𝐦𝐢𝐭: AI Proteins co-founder chris bahl explains the benefits of designing de novo miniproteins as therapeutics. #AlignSummit24 Full video: https://lnkd.in/gFCctRZq BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent